These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30100348)

  • 21. Direct One-Step Fluorescent Labeling of O-GlcNAc-Modified Proteins in Live Cells Using Metabolic Intermediates.
    Tan HY; Eskandari R; Shen D; Zhu Y; Liu TW; Willems LI; Alteen MG; Madden Z; Vocadlo DJ
    J Am Chem Soc; 2018 Nov; 140(45):15300-15308. PubMed ID: 30296064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of hypo-
    Mariappa D; Ferenbach AT; van Aalten DMF
    J Biol Chem; 2018 May; 293(19):7209-7221. PubMed ID: 29588363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. O-linked N-acetylglucosamine (O-GlcNAc) protein modification is increased in the cartilage of patients with knee osteoarthritis.
    Tardio L; Andrés-Bergós J; Zachara NE; Larrañaga-Vera A; Rodriguez-Villar C; Herrero-Beaumont G; Largo R
    Osteoarthritis Cartilage; 2014 Feb; 22(2):259-63. PubMed ID: 24333294
    [TBL] [Abstract][Full Text] [Related]  

  • 24. E. coli sabotages the in vivo production of O-linked β-N-acetylglucosamine-modified proteins.
    Goodwin OY; Thomasson MS; Lin AJ; Sweeney MM; Macnaughtan MA
    J Biotechnol; 2013 Dec; 168(4):315-23. PubMed ID: 24140293
    [TBL] [Abstract][Full Text] [Related]  

  • 25. O-GlcNAc modulation at Akt1 Ser473 correlates with apoptosis of murine pancreatic beta cells.
    Kang ES; Han D; Park J; Kwak TK; Oh MA; Lee SA; Choi S; Park ZY; Kim Y; Lee JW
    Exp Cell Res; 2008 Jul; 314(11-12):2238-48. PubMed ID: 18570920
    [TBL] [Abstract][Full Text] [Related]  

  • 26. O-GlcNAcylation of the human epidermal growth factor receptor.
    Stateva SR; Villalobo A
    Org Biomol Chem; 2015 Aug; 13(30):8196-204. PubMed ID: 26108188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. O-GlcNAcylation site mapping by (azide-alkyne) click chemistry and mass spectrometry following intensive fractionation of skeletal muscle cells proteins.
    Deracinois B; Camoin L; Lambert M; Boyer JB; Dupont E; Bastide B; Cieniewski-Bernard C
    J Proteomics; 2018 Aug; 186():83-97. PubMed ID: 30016717
    [TBL] [Abstract][Full Text] [Related]  

  • 28. '
    Zhao L; Shah JA; Cai Y; Jin J
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30082668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta-N-acetylglucosamine (O-GlcNAc) is part of the histone code.
    Sakabe K; Wang Z; Hart GW
    Proc Natl Acad Sci U S A; 2010 Nov; 107(46):19915-20. PubMed ID: 21045127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring leukocyte O-GlcNAcylation as a novel diagnostic tool for the earlier detection of type 2 diabetes mellitus.
    Springhorn C; Matsha TE; Erasmus RT; Essop MF
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4640-9. PubMed ID: 23066116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. O-GlcNAc cycling: implications for neurodegenerative disorders.
    Lazarus BD; Love DC; Hanover JA
    Int J Biochem Cell Biol; 2009 Nov; 41(11):2134-46. PubMed ID: 19782947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A study of the structural properties of sites modified by the O-linked 6-N-acetylglucosamine transferase.
    Britto-Borges T; Barton GJ
    PLoS One; 2017; 12(9):e0184405. PubMed ID: 28886091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. O-GlcNAc transferase inhibitors: current tools and future challenges.
    Trapannone R; Rafie K; van Aalten DM
    Biochem Soc Trans; 2016 Feb; 44(1):88-93. PubMed ID: 26862193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A highly effective and adjustable dual plasmid system for O-GlcNAcylated recombinant protein production in E. coli.
    Han C; Shan H; Bi C; Zhang X; Qi J; Zhang B; Gu Y; Yu W
    J Biochem; 2015 Jun; 157(6):477-84. PubMed ID: 25619971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular mechanisms regulating O-linked N-acetylglucosamine (O-GlcNAc)-processing enzymes.
    King DT; Males A; Davies GJ; Vocadlo DJ
    Curr Opin Chem Biol; 2019 Dec; 53():131-144. PubMed ID: 31654859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation.
    Smet-Nocca C; Broncel M; Wieruszeski JM; Tokarski C; Hanoulle X; Leroy A; Landrieu I; Rolando C; Lippens G; Hackenberger CP
    Mol Biosyst; 2011 May; 7(5):1420-9. PubMed ID: 21327254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting O-glycosyltransferase (OGT) to promote healing of diabetic skin wounds.
    Runager K; Bektas M; Berkowitz P; Rubenstein DS
    J Biol Chem; 2014 Feb; 289(9):5462-6. PubMed ID: 24398691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nuclear factor-erythroid-2 related transcription factor-1 (Nrf1) is regulated by O-GlcNAc transferase.
    Han JW; Valdez JL; Ho DV; Lee CS; Kim HM; Wang X; Huang L; Chan JY
    Free Radic Biol Med; 2017 Sep; 110():196-205. PubMed ID: 28625484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats.
    Akimoto Y; Hart GW; Wells L; Vosseller K; Yamamoto K; Munetomo E; Ohara-Imaizumi M; Nishiwaki C; Nagamatsu S; Hirano H; Kawakami H
    Glycobiology; 2007 Feb; 17(2):127-40. PubMed ID: 17095531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative regulation of nuclear pore complex proteins by O-GlcNAcylation.
    Mizuguchi-Hata C; Ogawa Y; Oka M; Yoneda Y
    Biochim Biophys Acta; 2013 Dec; 1833(12):2682-2689. PubMed ID: 23777819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.